Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Apr 1;99(7):1662–1672. doi: 10.1172/JCI119329

Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis.

P Goluszko 1, S L Moseley 1, L D Truong 1, A Kaul 1, J R Williford 1, R Selvarangan 1, S Nowicki 1, B Nowicki 1
PMCID: PMC507986  PMID: 9120010

Abstract

Escherichia coli that express Dr fimbriae and related adhesins recognize the common receptor decay accelerating factor. E. coli strains that express adhesins of the Dr family were postulated to be associated with cystitis (30-50%), pregnancy-associated pyelonephritis (30%), and chronic diarrhea (50%). In this study, we investigated the hypothesis that E. coli renal interstitial binding mediated by the Dr adhesin may be important for the development of chronic pyelonephritis. An insertional dra mutant, E. coli DR14, of the clinical E. coli isolate IH11128 bearing Dr fimbriae, was constructed and used to characterize persistence of infection and interstitial tropism in an experimental model of ascending pyelonephritis. Quantitative cultures of kidney homogenates indicated that Dr hemagglutinin positive (Dr+) E. coli IH11128 established a 1-yr colonization of renal tissue. In the Dr hemagglutinin negative (Dr-) group, 50% of animals cleared infection within 20 wk and 100% between 32 to 52 wk. Dr+ E. coli colonized the renal interstitium. Significant histological changes corresponding to tubulointerstitial nephritis including interstitial inflammation, fibrosis, and tubular atrophy were found in the kidney tissue of the Dr+ but not the Dr- group. A substantial amount of fimbrial antigen was detected in the parenchymal regions affected by interstitial inflammation and fibrosis. The obtained results are consistent with the hypothesis that mutation within the dra region, affecting E. coli binding to tubular basement membranes, prevented renal interstitial tropism and the development of the changes characteristically seen in tubulointerstitial nephritis.

Full Text

The Full Text of this article is available as a PDF (613.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arthur M., Johnson C. E., Rubin R. H., Arbeit R. D., Campanelli C., Kim C., Steinbach S., Agarwal M., Wilkinson R., Goldstein R. Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun. 1989 Feb;57(2):303–313. doi: 10.1128/iai.57.2.303-313.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bhagavan B. S., Wenk R. E., Dutta D. Pathways of urinary backflow in obstructive uropathy. Demonstration by pigmented gelatin injection and Tamm-Horsfall uromucoprotein markers. Hum Pathol. 1979 Nov;10(6):669–683. doi: 10.1016/s0046-8177(79)80111-2. [DOI] [PubMed] [Google Scholar]
  3. Bhathena D. B., Weiss J. H., Holland N. H., McMorrow R. G., Curtis J. J., Lucas B. A., Luke R. G. Focal and segmental glomerular sclerosis in reflux nephropathy. Am J Med. 1980 Jun;68(6):886–892. doi: 10.1016/0002-9343(80)90218-1. [DOI] [PubMed] [Google Scholar]
  4. Bilge S. S., Apostol J. M., Jr, Fullner K. J., Moseley S. L. Transcriptional organization of the F1845 fimbrial adhesin determinant of Escherichia coli. Mol Microbiol. 1993 Mar;7(6):993–1006. doi: 10.1111/j.1365-2958.1993.tb01191.x. [DOI] [PubMed] [Google Scholar]
  5. Bilge S. S., Clausen C. R., Lau W., Moseley S. L. Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea-associated Escherichia coli to HEp-2 cells. J Bacteriol. 1989 Aug;171(8):4281–4289. doi: 10.1128/jb.171.8.4281-4289.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Girón J. A., Jones T., Millán-Velasco F., Castro-Muñoz E., Zárate L., Fry J., Frankel G., Moseley S. L., Baudry B., Kaper J. B. Diffuse-adhering Escherichia coli (DAEC) as a putative cause of diarrhea in Mayan children in Mexico. J Infect Dis. 1991 Mar;163(3):507–513. doi: 10.1093/infdis/163.3.507. [DOI] [PubMed] [Google Scholar]
  7. Goetz M. B., Silverblatt F. J. Stimulation of human polymorphonuclear leukocyte oxidative metabolism by type 1 pili from Escherichia coli. Infect Immun. 1987 Mar;55(3):534–540. doi: 10.1128/iai.55.3.534-540.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gupta R., Ganguly N. K., Ahuja V., Joshi K., Sharma S. An ascending non-obstructive model for chronic pyelonephritis in BALB/c mice. J Med Microbiol. 1995 Jul;43(1):33–36. doi: 10.1099/00222615-43-1-33. [DOI] [PubMed] [Google Scholar]
  9. Hagberg L., Engberg I., Freter R., Lam J., Olling S., Svanborg Edén C. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun. 1983 Apr;40(1):273–283. doi: 10.1128/iai.40.1.273-283.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ichida S., Yuzawa Y., Okada H., Yoshioka K., Matsuo S. Localization of the complement regulatory proteins in the normal human kidney. Kidney Int. 1994 Jul;46(1):89–96. doi: 10.1038/ki.1994.247. [DOI] [PubMed] [Google Scholar]
  11. Johnson J. R., Skubitz K. M., Nowicki B. J., Jacques-Palaz K., Rakita R. M. Nonlethal adherence to human neutrophils mediated by Dr antigen-specific adhesins of Escherichia coli. Infect Immun. 1995 Jan;63(1):309–316. doi: 10.1128/iai.63.1.309-316.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Karr J. F., Nowicki B., Truong L. D., Hull R. A., Hull S. I. Purified P fimbriae from two cloned gene clusters of a single pyelonephritogenic strain adhere to unique structures in the human kidney. Infect Immun. 1989 Nov;57(11):3594–3600. doi: 10.1128/iai.57.11.3594-3600.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Korhonen T. K., Virkola R., Holthöfer H. Localization of binding sites for purified Escherichia coli P fimbriae in the human kidney. Infect Immun. 1986 Nov;54(2):328–332. doi: 10.1128/iai.54.2.328-332.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mangan D. F., Snyder I. S. Mannose-sensitive interaction of Escherichia coli with human peripheral leukocytes in vitro. Infect Immun. 1979 Nov;26(2):520–527. doi: 10.1128/iai.26.2.520-527.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Manoil C. Analysis of protein localization by use of gene fusions with complementary properties. J Bacteriol. 1990 Feb;172(2):1035–1042. doi: 10.1128/jb.172.2.1035-1042.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Marre R., Kreft B., Hacker J. Genetically engineered S and F1C fimbriae differ in their contribution to adherence of Escherichia coli to cultured renal tubular cells. Infect Immun. 1990 Oct;58(10):3434–3437. doi: 10.1128/iai.58.10.3434-3437.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Miettinen A., Westerlund B., Tarkkanen A. M., Törnroth T., Ljungberg P., Renkonen O. V., Korhonen T. K. Binding of bacterial adhesins to rat glomerular mesangium in vivo. Kidney Int. 1993 Mar;43(3):592–600. doi: 10.1038/ki.1993.87. [DOI] [PubMed] [Google Scholar]
  18. Miller V. L., Mekalanos J. J. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol. 1988 Jun;170(6):2575–2583. doi: 10.1128/jb.170.6.2575-2583.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mobley H. L., Chippendale G. R., Tenney J. H., Hull R. A., Warren J. W. Expression of type 1 fimbriae may be required for persistence of Escherichia coli in the catheterized urinary tract. J Clin Microbiol. 1987 Dec;25(12):2253–2257. doi: 10.1128/jcm.25.12.2253-2257.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mobley H. L., Jarvis K. G., Elwood J. P., Whittle D. I., Lockatell C. V., Russell R. G., Johnson D. E., Donnenberg M. S., Warren J. W. Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain. Mol Microbiol. 1993 Oct;10(1):143–155. doi: 10.1111/j.1365-2958.1993.tb00911.x. [DOI] [PubMed] [Google Scholar]
  21. Mundi H., Björkstén B., Svanborg C., Ohman L., Dahlgren C. Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring. Infect Immun. 1991 Nov;59(11):4168–4172. doi: 10.1128/iai.59.11.4168-4172.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nowicki B., Barrish J. P., Korhonen T., Hull R. A., Hull S. I. Molecular cloning of the Escherichia coli O75X adhesin. Infect Immun. 1987 Dec;55(12):3168–3173. doi: 10.1128/iai.55.12.3168-3173.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nowicki B., Hart A., Coyne K. E., Lublin D. M., Nowicki S. Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction. J Exp Med. 1993 Dec 1;178(6):2115–2121. doi: 10.1084/jem.178.6.2115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nowicki B., Holthöfer H., Saraneva T., Rhen M., Väisänen-Rhen V., Korhonen T. K. Location of adhesion sites for P-fimbriated and for 075X-positive Escherichia coli in the human kidney. Microb Pathog. 1986 Apr;1(2):169–180. doi: 10.1016/0882-4010(86)90019-7. [DOI] [PubMed] [Google Scholar]
  25. Nowicki B., Martens M., Hart A., Nowicki S. Gestational age-dependent distribution of Escherichia coli fimbriae in pregnant patients with pyelonephritis. Ann N Y Acad Sci. 1994 Aug 15;730:290–291. doi: 10.1111/j.1749-6632.1994.tb44268.x. [DOI] [PubMed] [Google Scholar]
  26. Nowicki B., Moulds J., Hull R., Hull S. A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen. Infect Immun. 1988 May;56(5):1057–1060. doi: 10.1128/iai.56.5.1057-1060.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Nowicki B., Svanborg-Edén C., Hull R., Hull S. Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli. Infect Immun. 1989 Feb;57(2):446–451. doi: 10.1128/iai.57.2.446-451.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nowicki B., Truong L., Moulds J., Hull R. Presence of the Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection. Am J Pathol. 1988 Oct;133(1):1–4. [PMC free article] [PubMed] [Google Scholar]
  29. Pham T., Kaul A., Hart A., Goluszko P., Moulds J., Nowicki S., Lublin D. M., Nowicki B. J. dra-related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recombinant decay-accelerating factor. Infect Immun. 1995 May;63(5):1663–1668. doi: 10.1128/iai.63.5.1663-1668.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Roberts J. A., Kaack M. B., Baskin G., Svenson S. B. Prevention of renal scarring from pyelonephritis in nonhuman primates by vaccination with a synthetic Escherichia coli serotype O8 oligosaccharide-protein conjugate. Infect Immun. 1993 Dec;61(12):5214–5218. doi: 10.1128/iai.61.12.5214-5218.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Roll F. J., Madri J. A., Albert J., Furthmayr H. Codistribution of collagen types IV and AB2 in basement membranes and mesangium of the kidney. an immunoferritin study of ultrathin frozen sections. J Cell Biol. 1980 Jun;85(3):597–616. doi: 10.1083/jcb.85.3.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Westerlund B., Kuusela P., Risteli J., Risteli L., Vartio T., Rauvala H., Virkola R., Korhonen T. K. The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol. 1989 Mar;3(3):329–337. doi: 10.1111/j.1365-2958.1989.tb00178.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES